Italia markets closed

Genprex, Inc. (0A8I.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,3601-0,0729 (-16,84%)
Alla chiusura: 02:54PM BST
Schermo intero
Chiusura precedente0,4330
Aperto0,3920
Denaro0,0000 x N/D
Domanda0,0000 x N/D
Min-Max giorno0,3601 - 0,3920
Intervallo di 52 settimane0,1903 - 7,9900
Volume9.300
Media Volume2.261
CapitalizzazioneN/D
Beta (mensile su 5 anni)-0,57
Rapporto PE (ttm)N/D
EPS (ttm)-0,3950
Prossima data utili12 nov 2024 - 18 nov 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC

    NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation,” please visit: https://nnw.fm/619wq More than 30 million pe